Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Immunovant (IMVT) Debt Ratio (2019 - 2023)

Immunovant filings provide 4 years of Debt Ratio readings, the most recent being 0.0 for Q1 2023.

  • Quarterly Debt Ratio rose 160.02% to 0.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was 0.0 through Mar 2023, up 160.02% year-over-year, with the annual reading at 0.0 for FY2023, 160.02% up from the prior year.
  • Debt Ratio hit 0.0 in Q1 2023 for Immunovant, up from 0.0 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.04 in Q2 2019 and bottomed at 0.0 in Q3 2020.
  • Average Debt Ratio over 4 years is 0.01, with a median of 0.0 recorded in 2019.
  • Peak annual rise in Debt Ratio hit 595.27% in 2020, while the deepest fall reached 98.61% in 2020.
  • Immunovant's Debt Ratio stood at 0.02 in 2019, then plummeted by 98.81% to 0.0 in 2020, then grew by 12.35% to 0.0 in 2022, then surged by 160.02% to 0.0 in 2023.
  • Per Business Quant, the three most recent readings for IMVT's Debt Ratio are 0.0 (Q1 2023), 0.0 (Q1 2022), and 0.0 (Q3 2020).